European-wide study confirms benefits of D-penicillamine and trientine for Wilson disease
Thursday, March 31, 2011 - 09:01
in Health & Medicine
Results from the first ever European-wide retrospective analysis presented today at the International Liver CongressTM have shown both D-penicillamine and trientine continue to be effective treatments, providing positive survival rates in patients with Wilson disease free from a liver transplant.